CLR-121125

N/A

Report date: 2025/11/28 17:54:29

NME

Base Information

Drug NameCLR-121125

Drug Alias NameCLR-121125

ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Iodine > 125IRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionIonising radiation emitters

TargetsUpdating

Therapy Area/IndicationsLung NeoplasmsColorectal NeoplasmsTriple Negative Breast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCellectar Biosciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesCellectar Biosciences Inc

Inactive CompaniesN/A

Active IndicationsLung NeoplasmsColorectal NeoplasmsTriple Negative Breast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A